Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin for Oxycodone Abuse Liability
NCT03415581Phase 2Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxazosin in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Feb 2017; status: terminated.
02
Drugs
doxazosin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03415581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415581.